Hariprasad Vankayalapati

4PUBLICATIONS
34CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 11, 2022
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.

Kristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann

|Oct 15, 2014
Inhibition of Nek2 by small molecules affects proteasome activity.

Lingyao Meng, Kent Carpenter, Alexis Mollard

Pageof 1